Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis mdm2'

Search results for: 'research area apoptosis mdm2'

Items 41-50 of 54

Page
per page
  1. Agouti-related Protein (AGRP) (25-82), human
    A1134 Agouti-related Protein (AGRP) (25-82), human
    Target: Melanocortin (MC) Receptors
    Summary: Agouti-related peptide(25-82)
      insoluble in EtOH; insoluble in DMSO; ≥100 mg/mL
  2. DMXAA (Vadimezan)
    A8233 DMXAA (Vadimezan)
     2 Citation
    Target: DT-diaphorases
    Summary: Tumnor vascular disrupting agent, apoptosis inducer
      insoluble in H2O; insoluble in EtOH; ≥14.1 mg/mL
  3. Elesclomol (STA-4783)
    A4386 Elesclomol (STA-4783)
     3 Citation
    Summary: Oxidative stress/apoptosis inducer,potent and novel
      insoluble in H2O; ≥20.15 mg/mL
  4. AEG 3482
    B9010 AEG 3482
    Target: JNK
    Summary: inhibitor of Jun kinase (JNK)-dependent apoptosis
      insoluble in EtOH; insoluble in H2O; ≥14 mg/mL
  5. GKT137831
    B4763 GKT137831
     1 Citation
    Target: NADPH Oxidases
    Summary: dual NADPH oxidase Nox1/Nox4 inhibitor
      ≥39.5 mg/mL
  6. LY2090314
    A3570 LY2090314
    Target: GSK-3
    Summary: Potent GSK-3 inhibitor
      insoluble in H2O; ≥91 mg/mL
  7. Vorinostat (SAHA, MK0683)
    A4084 Vorinostat (SAHA, MK0683)
     9 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL
  8. Puromycin aminonucleoside
    A3740 Puromycin aminonucleoside
     1 Citation
    Summary: Aminonucleoside portion of the antibiotic puromycin
      ≥14.45 mg/mL
  9. Tanshinone IIA
    N1846 Tanshinone IIA
    Target: AP-1|MAGL
    Summary: Antioxidant and anti-inflammatory reagent
      insoluble in EtOH; insoluble in H2O; ≥3.42 mg/mL
  10. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL

Items 41-50 of 54

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 11item
  2. Apoptosis 38item
  3. Chromatin/Epigenetics 5item
  4. Metabolism 3item
  5. MAPK Signaling 1 item
  6. Tyrosine Kinase 2item
  7. DNA Damage/DNA Repair 4item
  8. PI3K/Akt/mTOR Signaling 1 item
  9. Cell Cycle/Checkpoint 1 item
  10. Ubiquitination/ Proteasome 2item
  11. JAK/STAT Signaling 2item
  12. Angiogenesis 1 item
  13. Stem Cell 1 item
  14. Neuroscience 1 item
  15. Obesity, Appetite Control & Diabetes 1 item
  16. Other Signal Transduction 1 item
  17. Others 2item
  18. Immunology/Inflammation 3item
Reversibility
  1. Reversible 1 item
  2. Irreversible 4item
Target
  1. Caspases 9item
  2. Cyclin-Dependent Kinases 1 item
  3. Proteasome 1 item
  4. Histone Deacetylases (HDACs) 3item
  5. Inhibitor of apoptosis proteins (IAP) 2item
  6. Bcl-2 4item
  7. Raf 1 item
  8. Bcl-xl 2item
  9. MDM2 2item
  10. AP-1 1 item
  11. DT-diaphorases 1 item
  12. GSK-3 1 item
  13. VEGFR 2item
  14. PDGFR 1 item
  15. c-Kit 1 item
  16. RET 1 item
  17. Mcl-1 2item
  18. JNK 1 item
  19. Deubiquitinating enzymes (DUBs) 1 item
  20. STAT 1 item
  21. RIP kinases 1 item
  22. JAK 2item
  23. HSP90 1 item
  24. Survivin 1 item
  25. Ubiquitin-specific proteases 1 item
  26. Melanocortin (MC) Receptors 1 item
  27. MK2 1 item
  28. Fatty-acid-binding proteins (FABPs) 1 item
  29. COX 1 item
  30. NADPH Oxidases 1 item
  31. MAGL 1 item
  32. iNOS 1 item
  33. TRP Channel 1 item
  34. Apoptosis Inducers 1 item
  35. Cdc7 1 item
  36. angiogenesis 1 item
  37. p53-MDM2 interaction 1 item
  38. PC-PLC 1 item
  39. PKD 1 item
  40. Bcl-w 1 item
Reported Experiments
  1. Animal Experiments 44item
  2. Cell Experiments 29item
Related Disease
  1. Autoimmune Diseases 1 item
  2. Breast Cancer 10item
  3. Cancer 32item
  4. Chronic Lymphocytic Leukemia 1 item
  5. Chronic Myeloproliferative Disorders 1 item
  6. Colon Cancer 5item
  7. Colon Carcinoma 1 item
  8. Colorectal Cancer 3item
  9. Glioblastoma 4item
  10. Hepatocellular Carcinoma 1 item
  11. Inflammatory Diseases 2item
  12. Leukemia 1 item
  13. Lung Cancer 2item
  14. Lymphoma 4item
  15. Melanoma 4item
  16. Multiple Myeloma 1 item
  17. Myelofibrosis 1 item
  18. Myeloma 1 item
  19. Neuroblastoma 1 item
  20. Non-small Cell Lung Cancer 2item
  21. Ovarian Cancer 1 item
  22. Pain Relief 1 item
  23. Pancreatic Cancer 3item
  24. Prostate Cancer 7item
  25. Pulmonary Fibrosis 1 item
  26. Rheumatoid Arthritis 2item
  27. Soft Tissue Sarcoma 1 item
  28. Testicular Cancer 1 item
  29. Type 2 Diabetes 2item